UNIVERSITY COLLEGE LONDON
π¬π§United Kingdom
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
Phase 3
Completed
- Conditions
- Extrahepatic Bile Duct CancerGallbladder Cancer
- Interventions
- First Posted Date
- 2005-12-07
- Last Posted Date
- 2012-07-17
- Lead Sponsor
- University College, London
- Target Recruit Count
- 324
- Registration Number
- NCT00262769
- Locations
- π¬π§
Helen Rollason Cancer Care Centre at North Middlesex Hospital, London, England, United Kingdom
π¬π§Princess Royal Hospital at Hull and East Yorkshire NHS Trust, Hull, England, United Kingdom
π¬π§Leeds Cancer Centre at St. James's University Hospital, Leeds, England, United Kingdom
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
Phase 3
Completed
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabOther: No treatment
- First Posted Date
- 2005-06-03
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- University College, London
- Target Recruit Count
- 462
- Registration Number
- NCT00112931
- Locations
- π¬π§
Mount Vernon Cancer Centre at Mount Vernon Hospital, Northwood, England, United Kingdom
π¬π§West Middlesex University Hospital, Isleworth, England, United Kingdom
π¬π§Royal Alexandra Hospital, Paisley, Scotland, United Kingdom
Carboplatin and Etoposide With or Without Thalidomide in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer
Phase 3
Completed
- Conditions
- Lung Cancer
- Interventions
- Drug: Carboplatin, etoposide & thalidomideDrug: Carboplatin, etoposide & placebo
- First Posted Date
- 2003-06-06
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- University College, London
- Target Recruit Count
- 724
- Registration Number
- NCT00061919
- Locations
- π¬π§
University College of London Hospitals, London, England, United Kingdom
CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
Not Applicable
Completed
- Conditions
- Ovarian Cancer
- First Posted Date
- 2003-04-09
- Last Posted Date
- 2020-11-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 202638
- Registration Number
- NCT00058032
Β© Copyright 2025. All Rights Reserved by MedPath